About Adalimumab
Class: | Tumor Necrosis Factor (TNF) Inhibitor
Use: | Adalimumab is used to treat various autoimmune conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa.
Adult dose: | The standard adult dosing varies by condition. For rheumatoid arthritis, the typical dose is 40 mg every other week. For Crohn's disease and ulcerative colitis, an initial dose o
Drug Class
Tumor Necrosis Factor (TNF) Inhibitor
Uses & Indications
Adalimumab is used to treat various autoimmune conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, and hidradenitis suppurativa.
Storage Requirements
Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. If needed, it can be stored at room temperature up to 25°C (77°F) for a maximum of 14 days, after which it should be discarded if not used.
Manufacturer & Packaging
Manufacturer: AbbVie Deutschland GmbH & Co. KG, GERMANY
Package Size
1 Pre-Filled Pen + 2 Alcohol Pads in Blister
Price & Supplier
Price in UAE: AED 6867.00
Dosage Information
Adult Dose
The standard adult dosing varies by condition. For rheumatoid arthritis, the typical dose is 40 mg every other week. For Crohn's disease and ulcerative colitis, an initial dose of 160 mg on Day 1, followed by 80 mg on Day 15, and then 40 mg every other week starting on Day 29.
Pediatric Dose
Dosing for pediatric patients varies by condition and weight. For juvenile idiopathic arthritis, the dose is typically 20 mg every other week for patients weighing 15 kg to less than 30 kg, and 40 mg every other week for those weighing 30 kg or more.
Side Effects
Common side effects include injection site reactions, upper respiratory infections, headache, rash, and nausea.
Contraindications & Precautions
Adalimumab is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It should not be used in patients with severe infections, including sepsis and active tuberculosis.
Important Warnings
Important safety warnings include the risk of serious infections, such as tuberculosis and opportunistic infections, malignancies, including lymphoma, and the potential for allergic reactions. Regular monitoring for infections and malignancies is recommended.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.